The United States Food and Drug Administration will consider making Bharat Biotech’s Covaxin for use in the country, the biotechnology company said in a statement on Saturday.
Ocugen Inc announced that the FDA had lifted its hold on the company’s application to make it a vaccine candidate in the US.Covaxin is one of two Covid vaccines used for adults in India.
